Europe Cardiac Arrhythmia Monitoring Devices Market Analysis by Major Key Players: APPLIED CARDIAC SYSTEMS, BIOTELEMETRY, CARDIAC SCIENCE CORPORATION, GE HEALTHCARE, IRHYTHM TECHNOLOGIES, MEDI-LYNX CARDIAC MONITORING

Europe Cardiac Arrhythmia Monitoring Devices Market Highlights
The Europe cardiac arrhythmia monitoring devices market is expected to register a high CAGR during the forecast period, 2018 to 2023. Cardiac arrhythmia monitoring devices are extremely useful in tracking the heart function and report any abnormalities in normal function (rhythm). Hence, they not just help in maintaining a continuous record of heart function but have also proven to be lifesavers due to their ability to report abnormalities in normal heart function, like in the case of a cardiac event.

Get your sample report now @ https://marketprognosis.com/sample-request/16894
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Germany Lead the Market in Europe Region
The Germany cardiac arrhythmia monitoring devices market holds the largest market share in 2017 in Europe region due to the presence of quality healthcare system and presence of huge population with high rate of cardiac diseases in this region.

Key Developments in the Market:
• December 2017 u2013 Philips has acquired vital Health
• July 2017 u2013 BioTelemetry (BEAT) Acquired LifeWatch

Major Players:
APPLIED CARDIAC SYSTEMS INC., BIOTELEMETRY INC., CARDIAC SCIENCE CORPORATION, GE HEALTHCARE, IRHYTHM TECHNOLOGIES INC., MEDI-LYNX CARDIAC MONITORING LLC, PHILIPS HEALTHCARE, PREVENTICE SOLUTIONS, and MEDTRONICS, among others.

Get Discount on this report @ https://marketprognosis.com/discount-request/16894
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Increasing Use of Telecardiology
In disorders like cardiac arrhythmia, cardiac monitoring is not just essential but is needed continuously. As cardiac arrhythmia is not fully curable and since, it’s not practical to retain a patient in hospital for extremely long durations nor its practical to ask a patient to visit the hospital everyday (that too for several times a day in some cases), the best possible way to continuously monitor the patients suffering from cardiac arrhythmia is through remote patient monitoring by using the cardiac arrhythmia monitoring devices. This in technical terms is referred to as telecardiology. In telecardiology, the patients suffering from cardiac arrhythmia are given a cardiac arrhythmia-monitoring device, which is then fixed on the chest area of patients superficially. These devices monitor heart rhythm through a set of 2 to 3 electrodes and record any abnormalities in heart function and some of these devices can even autonomously record an abnormality and/or cardiac event and alert the healthcare professionals. Most of these devices can be monitored remotely and make it possible to effectively and efficiently monitor the patients suffering from cardiac arrhythmia. As it is extremely convenient to monitor the patients remotely when compared to regular patient visits to hospitals, telecardiology is becoming extremely popular both among the patients and the doctors. This growth in telecardiology means increase in demand for cardiac arrhythmia monitoring devices, which will ultimately drive the market for these devices. The other factors, such as ease of use and portability of cardiac arrhythmia monitoring devices and development of smart cardiac monitors are driving the Europe cardiac arrhythmia monitoring devices market.

Quality cannot be controlled by the Devices
Most of the cardiac arrhythmia monitoring devices comes with automatic analysis software, which analyses the signal. But, this analysis depends entirely on signal quality, which in turn is dependent on several different factors, such as proper attachment of the electrodes to the patient body, electromagnetic disturbance due to other devices in the vicinity, like the smart phones and other factors, such as muscle tremors. These devices cannot control these factors and often result in bad quality signal, which results in wrong analysis by the analysis software. But, often, this wrong analysis is considered by patients as the defect in the device itself and it is leading to loss of faith in these devices. This is ultimately affecting the sales of these devices and is hindering the growth of this market. The other factor, such as high cost of remote cardiac arrhythmia monitoring and unclear reimbursement policies is also hindering the growth of the Europe cardiac arrhythmia monitoring devices market.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/16894
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.